| mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.0076 |
0.9 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.0077 |
0.9 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |